Although NRAS mutations associated with malignant transformation have been predominantly detected in codons 12, 13 (exon 2), and 61 (exon 3), the most common NRAS gene mutation in cutaneous melanoma occurs at position 61, where glutamine (Q) is substituted by arginine (R), lysine (K), or leucine (L) (NRAS-Q61R/K/L). Here, NRAS is linked to cutaneous melanoma.